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AbstrACt
Introduction Pain following musculoskeletal trauma 
is common with poor outcomes and disability well 
documented. Pain is complex in nature and can include 
the four primary mechanisms of pain: nociceptive, 
neuropathic, inflammatory and central sensitisation 
(CS). CS can be measured in multiple ways; however, 
no systematic review has evaluated the measurement 
properties of such measures in the musculoskeletal 
trauma population. This systematic review aims to 
evaluate the measurement properties of current measures 
of CS in this population.
Methods/analysis This protocol is informed and reported 
in line with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis-P. MEDLINE, EMBASE, CINAHL, 
ZETOC, Web of Science, PubMed and Google Scholar as 
well as key journals and grey literature will be searched 
in two stages to (1) identify what measures are being 
used to assess CS in this population and (2) evaluate the 
measurement properties of the identified measures. Two 
independent reviewers will conduct the search, extract the 
data, assess risk of bias for included studies and assess 
overall quality. The Consensus-based Standards for the 
selection of Health Measurement Instruments Risk of Bias 
Checklist and a modified Grading of Recommendations, 
Assessment, Development and Evaluation guidelines 
will be used. Meta-analysis will be conducted if deemed 
appropriate. Alternatively, a narrative synthesis will be 
conducted and summarised per measurement property per 
outcome measure.
Ethics and dissemination This review will aid clinicians 
in using the most appropriate tool for assessing central 
sensitisation in this population and is the first step towards 
a more standardised approach in pain assessment. The 
results of this study will be submitted to a peer reviewed 
journal and presented at conferences.
PrOsPErO registrationnumber CRD42018091531.
IntrOduCtIOn  
Pain is a common occurrence following 
musculoskeletal trauma and is routinely 
assessed in both research and clinical prac-
tice. Many methods exist for assessing pain 
and commonly include patient reported 
outcome measures (PROMs) such as the 
Numerical Rating Scale or the McGill Pain 
Questionnaire.1 Many of these measures have 
established measurement properties and are 
recommended as outcome measures for clin-
ical trials in chronic pain populations.1 
However, these methods are limited to 
being patient reported and often focus only 
on pain intensity.2 While this is relevant and 
focuses on patient perception and impact of 
pain, this does not identify the neurophysio-
logical mechanisms driving pain perception.3 
Identifying the underlying pain mechanisms 
for individual patients has the potential to 
allow more targeted treatments resulting in 
better outcomes.4 Furthermore, measures 
that incorporate the four domains (body 
function, activities and participation, body 
structure and environmental factors) of the 
International Classification of Functioning, 
Disability and Health allow a more holistic 
approach in assessing patients.5
Four main pain mechanisms have been 
described: nociceptive (activation of noci-
ceptors from actual or threatened tissue 
damage), neuropathic (damage, lesion or 
strengths and limitations of this study
 ► This is the first systematic review to evaluate mea-
surement properties of central sensitisation  (CS) 
outcome measures in the musculoskeletal trauma 
population.
 ► This study utilises the new Consensus-based 
Standards for the selection of Health Measurement 
Instruments  Risk of Bias tool for systematic reviews 
to evaluate methodological quality.
 ► While assessing other pain outcome measures in 
this population would be beneficial, this study is lim-
ited to measures of CS only.
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disease of the somatosensory nervous system), inflamma-
tory (nociceptors activated by inflammatory mediators 
due to tissue damage) and central sensitisation (CS).4 6 CS 
can be described when the central nervous system adapts 
and amplifies pain, often when tissue healing has taken 
place and no further pathology or disease process can 
be identified.4 7 CS results from increased excitability of 
central nociceptive neurons in the cortex, brain stem, 
trigeminal nucleus and spinal cord.8 A number of mech-
anisms have been implicated in long-term CS, including 
cortical reorganisation and maladaptive neuroplasticity, 
alterations in neurochemistry, loss of inhibitory neurons, 
alerted glial activity, dysfunction of endogenous pain 
control mechanisms, alterations in grey-matter volume 
and altered structural integrity and connectivity of white 
matter.8 This results in general hypersensitivity of the 
somatosensory system, presenting with symptoms such 
as widespread pain, tactile allodynia, secondary hyperal-
gesia and a heightened response to non-noxious stimuli.7 
With multiple presentations and features, the underlying 
pathophysiological cause of CS is debated within the 
literature;3 7 therefore, CS is often regarded as a concept 
rather than a true diagnostic label.
Features of CS have been identified in many chronic 
pain disorders such as osteoarthritis, fibromyalgia, 
chronic whiplash-associated disorders and low back 
pain.7 9–11 Patients presenting with symptoms of CS typi-
cally show higher pain ratings,12 greater disability,13 are 
more likely to develop future musculoskeletal condi-
tions14 and show poorer outcomes and increased likeli-
hood of developing chronic pain.15 Features of CS have 
also been observed within the early stages of acute injury, 
for example, following a whiplash trauma, and have been 
shown to be predictive of poorer outcome in this popu-
lation.16 17
Within musculoskeletal trauma, poor outcomes and 
disability are well documented,18–20 with the question of 
why some people fully recover when others do not still to 
be answered. Recent studies recognise this issue within 
musculoskeletal trauma and are moving towards a more 
mechanistic approach in assessing patients to optimise 
recovery.21 While not all musculoskeletal trauma patients 
will present with features of CS, and be the main cause 
of poor outcome, it should not be ruled out as a cause or 
predictor of poor recovery and should be included within 
assessment of pain.
Various methods exist to assess CS including quantita-
tive sensory testing (QST),3 which aims to assess the func-
tion of the somatosensory system using various methods 
such as thermal and pressure pain thresholds,22 23 pain 
drawings where more widespread symptoms can be 
assessed3 and PROMs such as the Central Sensitisation 
Inventory24 which incorporate common symptoms of 
CS. The measurement properties of these measures have 
been reported; however, the population sample is often 
healthy volunteers25 or an alternative population group22 
which questions the value of these measures within a 
specific population such as musculoskeletal trauma.26
Established measurement properties for outcome 
measures are needed to avoid any potential bias and to 
be confident in findings when making recommenda-
tions.27 To inform and improve the selection of outcome 
measures, the Consensus-based Standards for the selec-
tion of Health Measurement instruments (COSMIN) 
initiative developed a consensus-based taxonomy of 
measurement properties with three main domains iden-
tified—reliability, validity and responsiveness— all having 
further subgroups of measurement properties.28 Further-
more, the COSMIN Checklist to assess methodological 
quality is a well-used tool both in systematic reviews and 
design and reporting of a study on measurement proper-
ties. A recent updated tool has been introduced specifi-
cally to use in systematic reviews.29 30
Currently, within musculoskeletal trauma, a vast 
range of measures are used to assess CS, highlighting 
a lack of consensus or gold standard measurement.31 32 
Previous systematic reviews investigating musculoskeletal 
pain and injury have highlighted the lack of consensus 
on the optimal measure of CS,31 33 all finding poor or 
limited methodological quality within the studies.33 34 All 
reviews have used different tools to measure quality, with 
meta-analysis not possible due to the heterogeneity of 
included studies, making conclusions and clinical impli-
cations difficult. A systematic review is needed to synthe-
sise and evaluate current practice in assessing CS to allow 
a more standardised approach, as well as being the first 
systematic review specifically investigating the muscu-
loskeletal trauma population. Specifically, the primary 
aim of this systematic review is to investigate if current 
outcome measures of CS have established measurement 
properties in the musculoskeletal trauma population, 
with a secondary aim to inform and summarise what 
measures are currently being used in this population.
MEthOds
This systematic review has been designed following 
scoping searches of the available literature and is reported 
in accordance to Preferred Reporting Items for System-
atic Reviews and Meta-Analysis-P guidelines (online 
supplementary file 1).35
Eligibility criteria
Inclusion criteria
Population
Any study that examined an adult population (aged ≥16 
years) who experienced any type of musculoskeletal 
trauma. For the purpose of this review, musculoskeletal 
trauma will be defined as any musculoskeletal struc-
ture for example, bones, joints, ligaments, tendons and 
muscles that surround these structures involved in a trau-
matic injury.36 Examples of a traumatic injury include 
road traffic collisions, falls and gunshot and stab wounds. 
Studies that specifically investigate a population such 
as people following a whiplash injury will be included 
as this is deemed musculoskeletal in nature despite this 
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population often being segregated and investigated indi-
vidually. This is to ensure that the musculoskeletal trauma 
population is represented fully in this review. For studies 
with mixed aetiology, majority of the sample must be 
musculoskeletal in nature (>90%), a figure previously 
used in systematic reviews in this population.36
Outcome measures
Any study that evaluates CS using a specific outcome 
measure will be included. With no gold standard measure 
for CS, this makes defining eligibility criteria challenging. 
In order to establish robust criteria, the following criteria 
are based on current consensus in the literature and 
previous systematic reviews in the field.4 7–9 31 32
Studies will be included if one of the following is 
highlighted:
1. Reference to sensitisation of the central nervous sys-
tem using terms such as CS, central sensitivity, central 
pain modulation and widespread pain.
2. Reference to sensitisation symptoms specifically 
around sensory changes such as secondary hyperalge-
sia and tactile allodynia—symptoms well documented 
as indicators of CS.7
Outcome measures being defined as any one of the 
following:
1. Patient-reported measures or questionnaires designed 
specifically to assess CS.
2. Performance-based measures designed to assess as-
pects of CS, an example being QST—a term encom-
passing multiple sensory testing methods, which has 
been established as a good measure of features of CS.31
3. Measures that are evaluating symptoms of CS, for ex-
ample, widespread pain using pain drawings.
Measurement properties
Any study that has evaluated one or more measurement 
properties will be included in this study. This will include 
all measurement properties included in the three main 
domains (reliability, validity and responsiveness) of the 
COSMIN Taxonomy.27 28 Definitions of measurement 
properties will be in line with the COSMIN taxonomy and 
are summarised in online supplementary file 2.
Study design
Any study design apart from case studies and previous 
literature reviews including systematic reviews and 
meta-analyses will be included in this study—this includes 
randomised controlled trials, cohort studies, and obser-
vational studies.
Timing and setting
No restriction on length of study will be used in this 
review, and all-time points will be included, for example, 
from point of injury onwards. No restriction on setting 
will be used in this review.
Exclusion criteria
Any study where the primary injury is a traumatic brain 
injury, burns or neurological injury such as spinal cord 
injuries will be excluded. These subgroups of patients 
will be excluded due to various other specific measures 
being developed for these patients, for example, neuro-
logical-specific PROMs validated in this population,37 
together with other factors such as reduced consciousness 
and pain not a primary factor in recovery, for example, 
brain injury.38 Papers that are not written in English will 
be excluded.
Information sources
A search strategy has been developed using medical 
subject headings, where available, and relevant text words 
relating to musculoskeletal trauma, CS and measurement 
properties. Databases to be encompassed in the search will 
include MEDLINE (OVID interface), EMBASE (OVID 
interface), CINAHL (EBSCO interface), ZETOC, Web of 
Science, PubMed and Google Scholar from inception.
Hand searching of key journals such as Musculoskel-
etal Science and Practice, PAIN, European Journal of Pain, 
The Journal of Pain and The Clinical Journal of Pain as well 
as contacting relevant leading researchers in the field 
will be conducted. Grey literature searching will include 
British National bibliography for report literature, open-
Grey, dissertation abstracts and EThOS.
search strategy
Two independent reviewers will complete the search and 
identify potential studies to be included in the review. No 
study design, date or language limits will be used during 
the search, to ensure that no relevant studies are missed. 
An initial MEDLINE search strategy will be developed 
and then adapted with relevant syntax and subject head-
ings for other databases. Recommended search filters 
specifically designed for retrieving articles on measure-
ment properties will be used where appropriate.39 40
The search will take place in two stages:
1. Initial search to identify the outcome measures used in 
the musculoskeletal trauma population.
2. Secondary search identifying studies assessing mea-
surement properties. This secondary search will focus 
on the outcome measures that were identified in the 
first search only.
In the event that there are a limited number of studies 
to evaluate measurement properties (four or less) in the 
specific population of adult musculoskeletal trauma, the 
secondary search will be widened to general musculoskel-
etal conditions such as osteoarthritis and fibromyalgia or 
healthy subjects, but findings will be evaluated and synthe-
sised separately. Healthy subjects will be included as well 
as musculoskeletal conditions in order to capture studies 
that have evaluated measurement properties such as reli-
ability, which can then inform future studies in a sympto-
matic population. An example of the search strategy for 
both stages is summarised in online supplementary file 3.
data management
All search results will be uploaded and stored on 
Endnote Version X8 (Clarivate Analytics) software 
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programme. This will allow any duplicates to be identi-
fied and removed. Abstracts and full texts will be stored 
on Endnote. Screening questions and forms will be devel-
oped based on inclusion/exclusion criteria for the title 
and abstract screening and full-text retrieval.
study selection
Two reviewers will independently screen titles/abstracts 
against the prespecified inclusion/exclusion criteria and 
subcategorise into include/exclude/unsure.41 Full texts 
will then be obtained for all articles that appear to meet 
the inclusion criteria. If there is uncertainty in inclusion 
criteria for a specific paper, the full text will be retrieved 
for further clarification.42 Authors will be contacted for 
additional information if required. Screening of full 
texts will be conducted in the same manner using the 
predefined criteria and conducted independently.
At both stages, articles will be included if both authors 
agree that the eligibility criteria are met. Any disagree-
ment between the two reviewers will be first discussed in a 
consensus meeting between the reviewers, and if needed 
an independent reviewer sought if no agreement can be 
made. Information on excluded studies and reasons for 
exclusion will be collated and reported.
data collection process
A standardised form developed for this review will be 
used to extract information from included studies. Both 
reviewers will independently extract information, with 
one reviewer then collating the information. Any disagree-
ments between the reviewers will be discussed and/or 
reviewed by a third reviewer. Prior to data collection, a 
pilot of the data collection form will be conducted to 
ensure all relevant information is collected, and updated 
if needed.
data items
The items to be extracted from included studies are 
summarised in table 1. Authors will be contacted for 
clarification and any missing data if needed. In the event 
of two or more papers being identified from the same 
study, authors will be contacted for further information 
to ensure the data are not duplicated in the review.
Outcomes and prioritisation
As no gold standard method exists for CS, no primary 
outcome measure is identified for this review.
risk of bias in individual studies
The COSMIN Risk of Bias Checklist for systematic reviews 
will be used for risk of bias and methodological quality in 
individual studies.29 Revised from the original COSMIN 
Checklist, this new tool is specifically designed to evaluate 
studies on measurement properties in systematic reviews. 
The new checklist includes standards for each measure-
ment property for both design and preferred statis-
tical methods, and rates each study as either very good, 
adequate, doubtful and inadequate quality.29 40 Although 
currently no literature exists on the measurement prop-
erties of the new tool, the previous COSMIN Checklist 
demonstrated adequate reliability,43 a basis from which 
this new tool has subsequently been developed. As the 
COSMIN Risk of Bias Checklist was originally developed 
for PROMs, as with previous COSMIN tools, it can be 
adapted for other measures that are not PROMs, which 
is recommended by the COSMIN group.40 As with the 
screening process, two independent reviewers will assess 
and score the risk of bias for all included studies. Any 
disagreements between the two reviewers will be discussed 
in a consensus meeting. If no agreement can be made, 
again a third reviewer will be consulted. The percentage 
of agreement between the two reviewers will be reported 
in the results section of the final review.
data synthesis
Following scoping searches of current available literature 
together with the heterogeneity of the population, pooling 
of data may not be possible; however, it will not be ruled 
out and will be assessed prior to synthesis and conducted 
if possible. If deemed not possible, a narrative synthesis 
will be conducted. Synthesis of results will follow recom-
mendations from the COSMIN guidelines for systematic 
reviews.40 Individual studies will be assessed for method-
ological quality and rated against the predefined criteria 
for good measurement properties (online supplementary 
file 2).40 44 Evidence will be pooled or summarised per 
measurement property per outcome measure with the 
overall result rated again against the criteria for good 
measurement properties. The overall quality of evidence 
will then be assessed using a modified Grading of Recom-
mendations Assessment, Development and Evaluation 
(GRADE) approach.40
Meta-biases
In order to determine whether any reporting bias is 
present, a detailed search for unpublished studies will be 
conducted, for example, accessing any past conference 
proceedings in the last 10 years, and internet searches, 
Table 1 Summary of items to be extracted from included 
studies
Content Data items
General study Information Authors, year of publication
Study characteristics Sample size, study design, 
measurement time points, 
country
Patient characteristics Age, gender, type of trauma, 
mechanism of trauma, duration 
of symptoms
Outcome measures CS outcome measures
Other outcome measures used
Measurement properties Measurement properties 
assessing statistical methods 
used and results
CS, central sensitisation. 
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with consistency between protocols and published studies 
examined, if protocols are available. Currently, no trial 
registry exists for measurement property studies; there-
fore, trial registries will not be searched.
Confidence in cumulative evidence
Overall strength and quality of evidence will be inves-
tigated using a modified GRADE approach as recom-
mended by the COSMIN guidelines for systematic 
reviews.40 Four of the GRADE factors will be used: risk 
of bias, inconsistency, imprecision and indirectness with 
publication bias being omitted. This is due to the diffi-
culty in assessing this factor due to no registry currently 
existing for measurement properties.40
Patient and public involvement
The research question in this study was developed 
following consultations and discussion within patient 
and public involvement meetings. Patients will not be 
involved in the analysis and data collection of the system-
atic review.
Clinical implications of this study
CS is complex in nature and can cause significant disability 
and pain for individuals. This in turn can impact on an 
individual’s recovery and other factors such as return to 
work rate following injury. A timely and accurate diag-
nosis by clinicians will allow tailored management and 
better outcome, in which outcome measures can comple-
ment diagnosis. The definition of CS itself is challenging, 
with multiple symptoms and clinical presentations, for 
example, the onset of CS can often be attributed to tissue 
damage or nerve injury, but in some cases no peripheral 
pathology exists.45 Established measurement properties 
of outcome measures are needed in clinical practice and 
research in order to use the most appropriate tool. This 
systematic review will allow clinicians to make informed 
decisions on the most appropriate outcome measures 
when assessing CS, working towards a more standardised 
approach of CS assessment. This systematic review will 
inform both clinical practice and further research into 
this topic.
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